comparemela.com

Latest Breaking News On - Prnewswire nasus pharma - Page 1 : comparemela.com

Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection

/PRNewswire/ Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address.

United statesBarbaraj mannElla mendelsonH hypromellose taffixNasus pharmaMicha gladnikoffPrnewswire nasus pharmaMegiddo daliaG brett moreauYaron droriKlang shmuelDalia megiddoMichal mandelboimNaparstek yaakovUdi gilboaNasus pharma ltd

Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection

/PRNewswire/ Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address.

United statesBarbaraj mannElla mendelsonH hypromellose taffixNasus pharmaMicha gladnikoffPrnewswire nasus pharmaMegiddo daliaG brett moreauYaron droriKlang shmuelDalia megiddoMichal mandelboimNaparstek yaakovUdi gilboaNasus pharma ltd

Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection

NP-003 study terminated early with high significance in reducing viral infection. TEL AVIV , Israel, Nov. 24, 2021 /PRNewswire/ Nasus Pharma a privately held clinical-stage biopharmaceutical

United statesBarbaraj mannElla mendelsonH hypromellose taffixNasus pharmaMicha gladnikoffPrnewswire nasus pharmaMegiddo daliaG brett moreauKostenloser wertpapierhandelYaron droriKlang shmuelDalia megiddoMichal mandelboimNaparstek yaakovUdi gilboa

Taffix® regains marketing approval in Spain

/PRNewswire/ Nasus Pharma, a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) therapeutic solutions today.

United statesStaatliches gewerbeaufsichtsamtNasus pharmaDalia megiddoPrnewswire nasus pharmaUdi gilboaDevices agencySpanish medicinesMedical devices agencyLatin americaMiddle eastIntranasal naloxoneIntranasal epinephrineHealth care amp hospitalsMedical pharmaceuticalsEuropean government

Taffix® regains marketing approval in Spain

Taffix® regains marketing approval in Spain
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesStaatliches gewerbeaufsichtsamtNasus pharmaDalia megiddoPrnewswire nasus pharmaUdi gilboaDevices agencySpanish medicinesMedical devices agencyLatin americaMiddle eastIntranasal naloxoneIntranasal epinephrineஒன்றுபட்டது மாநிலங்களில்டாலியா மேகித்தோஊதி கில்போவா

vimarsana © 2020. All Rights Reserved.